Press Centre

Venatorx Pharmaceuticals and GARDP partner to develop new antibiotic for hospital acquired infections with limited treatment options

GARDP and Venatorx Pharmaceuticals today announced a collaboration to accelerate the development of cefepime-taniborbactam, an investigational combination of the fourth-generation antibiotic cefepime with taniborbactam, a novel, broad-spectrum beta-lactamase inhibitor that restores the activity of cefepime against carbapenem-resistant Enterobacterales (CRE) and carbapenem-resistant Pseudomonas aeruginosa (CRPA).

GARDP announces Dr Mercedes Tatay as new Board member

The Global Antibiotic Research and Development Partnership (GARDP) is pleased to announce that Dr Mercedes Tatay has joined the Board. As a specialist in infectious diseases with a remarkable track record working with Médecins Sans Frontières (MSF) on humanitarian medical responses and public health interventions, Dr Tatay brings exceptional experience in ensuring treatments are developed […]

Dutch Ministry of Health, Welfare and Sport renews commitment to support GARDP

BERLIN – The Global Antibiotic Research and Development Partnership (GARDP) is pleased to announce continued support from the Dutch Ministry of Health, Welfare and Sport. The funding of €5 million will be used to support GARDP’s efforts to develop new treatments for drug-resistant infections and to ensure sustainable access, promoting responsible use and affordability to […]

We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.